On April 23, we suggested investors take a bullish posture on NVO, the maker of Ozempic (a popular diabetes therapy) and Wegovy (the popular weight loss drug). This article is for paid members - please login or subscribe for access. Username Password Remember Me Forgot Password Share: Mark W. Guthner, CFA Previous Post Apple Inc: AAPLNext PostDollar General: DG You Might Also Like March 22, 2023 What up with Bonds? (TLT) and Close some trades November 7, 2023 GlaxoSmithKline: Trade Update: GSK August 28, 2025
You Might Also Like March 22, 2023 What up with Bonds? (TLT) and Close some trades November 7, 2023 GlaxoSmithKline: Trade Update: GSK August 28, 2025
